Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia

Clinical trial NCT06944119 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06944119
Sponsor: Tel-Aviv Sourasky Medical Center
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Myeloma Lymphoma CLL Myelodysplastic Syndrome Leukemia Acute Myeloid - AML

Start date: 2025-01-20
Primary completion: 2026-06-30
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.